68 results on '"Van de Velde, C."'
Search Results
2. Clinical translation and implementation of optical imaging agents for precision image-guided cancer surgery
3. ASO Author Reflections: Can Utilization of Cancer Registry Data Contribute to Solving the Lack of Evidence for Older Pancreatic Cancer Patients?
4. Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study
5. Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
6. Impact of upfront randomization for postoperative treatment on quality of surgery in the CRITICS gastric cancer trial
7. Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium
8. Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study
9. Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study
10. EpCAM as multi-tumour target for near-infrared fluorescence guided surgery
11. Association Between the Most Frequent Complications After Surgery for Stage I–III Colon Cancer and Short-Term Survival, Long-Term Survival, and Recurrences
12. Validity of the online PREDICT tool in older patients with breast cancer: a population-based study
13. CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
14. Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
15. The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
16. Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
17. Erratum: Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
18. Characterization and Evaluation of the Artemis Camera for Fluorescence-Guided Cancer Surgery
19. Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
20. Choosing relevant endpoints for older breast cancer patients in clinical trials: an overview of all current clinical trials on breast cancer treatment
21. Combined analysis of biomarkers of proliferation and apoptosis in colon cancer: an immunohistochemistry-based study using tissue microarray
22. Immunological subtypes in breast cancer are prognostic for invasive ductal but not for invasive lobular breast carcinoma
23. The Diagnostic Value of One-Step Nucleic acid Amplification (OSNA) for Sentinel Lymph Nodes in Colon Cancer Patients
24. Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancer
25. Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer
26. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
27. Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
28. CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial
29. Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854)
30. Assessment of DNA methylation status in early stages of breast cancer development
31. Postoperative complications and survival of elderly breast cancer patients: a FOCUS study analysis
32. TEAM II: a randomised, multicentre, prospective, phase III trial investigating neoadjuvant hormonal therapy with exemestane for three versus six months (TEAM IIa) and/or the efficacy and safety of the addition of ibandronate to adjuvant hormonal therapy in post-menopausal women with hormone receptor positive early breast cancer (TEAM IIb)
33. Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
34. Use of Aspirin postdiagnosis improves survival for colon cancer patients
35. Erratum: Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
36. Surgical treatment of early stage breast cancer in elderly: an international comparison
37. Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer
38. Inclusion and Analysis of Older Adults in RCTs
39. Socioeconomic differences in survival among breast cancer patients in the Netherlands not explained by tumor size
40. 2010 SSO John Wayne Clinical Research Lecture: Rectal Cancer Outcome Improvements in Europe: Population-Based Outcome Registrations will Conquer the World
41. Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients
42. Patterns of Local Recurrence in Rectal Cancer: A Single-Center Experience
43. Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients
44. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model
45. Patterns of Local Recurrence in Rectal Cancer: A Single-Center Experience
46. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer
47. Benefit from preoperative radiotherapy in rectal cancer treatment: disease-free patients' and oncologists' preferences
48. How important is the opinion of significant others to cancer patients’ adjuvant chemotherapy decision-making?
49. Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer
50. Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.